Zobrazeno 1 - 10
of 220
pro vyhledávání: '"Shelly A, McNeil"'
Autor:
Henrique Pott, Jason J. LeBlanc, May ElSherif, Todd F. Hatchette, Shelly A. McNeil, Melissa K. Andrew, the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract We developed and validated the Influenza Severity Scale (ISS), a standardized risk assessment for influenza, to estimate and predict the probability of major clinical events in patients with laboratory-confirmed infection. Data from the Cana
Externí odkaz:
https://doaj.org/article/3f00e81018c54b0280c50e252ac49d5c
Autor:
Sydney George, Jessica Regan, Amnah Awan, Meaghan O’Connor, April Foster, Kimberly Raymond, Iris Gorfinkel, Shelly A. McNeil
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTThis qualitative, cross-sectional study aimed to understand the barriers and facilitators related to the adherence and completion of the recombinant zoster vaccine (RZV) two-dose series in Canada, as perceived by healthcare providers (HCPs) a
Externí odkaz:
https://doaj.org/article/882ef0cde00f4d719215addca2b4946b
Autor:
Henrique Pott, Jason J. LeBlanc, May S. ElSherif, Todd F. Hatchette, Shelly A. McNeil, Melissa K. Andrew, on behalf of the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Influenza and RSV coinfections are not commonly seen but are concerning as they can lead to serious illness and adverse clinical outcomes among vulnerable populations. Here we describe the clinical features and outcomes of influen
Externí odkaz:
https://doaj.org/article/e1635e441cdb493b8157f35718201866
Autor:
Elizabeth Simms, Gregory R. McCracken, Todd F. Hatchette, Shelly A. McNeil, Ian Davis, Noella Whelan, Angela Keenan, Jason J. LeBlanc, Glenn Patriquin
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 6 (2023)
ABSTRACT In hospitals during the COVID-19 pandemic, laboratory testing was important to reduce SARS-CoV-2 transmissions, particularly for high-risk settings like the emergency department and pre-operative settings and for the safe return to work of e
Externí odkaz:
https://doaj.org/article/c2a276ae094a457fbda62893d5bf7854
Autor:
Melissa K. Andrew, Shelly A. McNeil
Publikováno v:
The Lancet Regional Health. Europe, Vol 14, Iss , Pp 100312- (2022)
Externí odkaz:
https://doaj.org/article/f63f7d04436b486c823424fa9d0e83d7
Autor:
Bruno Lina, Alexandre Georges, Elena Burtseva, Marta C. Nunes, Melissa K. Andrew, Shelly A. McNeil, Guillermo M. Ruiz-Palacios, Luzhao Feng, Jan Kyncl, Philippe Vanhems, Justin R. Ortiz, John Paget, Robert C. Reiner, on behalf of the GIHSN 2017–2018 study collaborators
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background Since 2011, the Global Influenza Hospital Surveillance Network (GIHSN) has used active surveillance to prospectively collect epidemiological and virological data on patients hospitalized with influenza virus infection. Here, we de
Externí odkaz:
https://doaj.org/article/2ee14519483e431ca362eab1b5f3da09
Autor:
Joanne M. Langley, Soren Gantt, Caroline Quach, Julie A. Bettinger, Scott A. Halperin, Jill Mutch, Shelly A. McNeil, Brian J. Ward, Donna MacKinnon-Cameron, Lingyun Ye, Kim Marty, David Scheifele, Erin Brown, Joenel Alcantara
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 3, Pp 454-462 (2020)
Emergency vaccination programs often are needed to control outbreaks of meningococcal disease caused by Neisseria meningitidis serogroup B (MenB) on college campuses. Such campaigns expend multiple campus and public health resources. We conducted a r
Externí odkaz:
https://doaj.org/article/04902ddb4cd3493d8cc5b35557392d91
Autor:
Lidia Oostvogels, Thomas C. Heineman, Robert W. Johnson, Myron J. Levin, Janet E. McElhaney, Peter Van den Steen, Toufik Zahaf, Alemnew F. Dagnew, Roman Chlibek, Javier Diez-Domingo, Iris S. Gorfinkel, Caroline Hervé, Shinn-Jang Hwang, Hideyuki Ikematsu, George Kalema, Himal Lal, Shelly A. McNeil, Tomas Mrkvan, Karlis Pauksens, Jan Smetana, Daisuke Watanabe, Lily Yin Weckx, Anthony L. Cunningham
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 12, Pp 2865-2872 (2019)
In two pivotal efficacy studies (ZOE-50; ZOE-70), the adjuvanted recombinant zoster vaccine (RZV) demonstrated >90% efficacy against herpes zoster (HZ). Adults aged ≥50 or ≥70 years (ZOE-50 [NCT01165177]; ZOE-70 [NCT01165229]) were randomized to
Externí odkaz:
https://doaj.org/article/2de77cc0739443df82239135c7c026b5
Autor:
Mary K. Foley, Samuel D. Searle, Ali Toloue, Ryan Booth, Alec Falkenham, Darryl Falzarano, Salvatore Rubino, Magen E. Francis, Mara McNeil, Christopher Richardson, Jason LeBlanc, Sharon Oldford, Volker Gerdts, Melissa K. Andrew, Shelly A. McNeil, Barry Clarke, Kenneth Rockwood, David J. Kelvin, Alyson A. Kelvin
Publikováno v:
EClinicalMedicine, Vol 37, Iss , Pp 100975- (2021)
Background: The SARS-CoV-2 (Severe Acute Respiratory Syndrome coronavirus 2) has led to more than 165 million COVID-19 cases and >3.4 million deaths worldwide. Epidemiological analysis has revealed that the risk of developing severe COVID-19 increase
Externí odkaz:
https://doaj.org/article/26fed214eda74bfea0592291fe6e393f
Autor:
Dominique Rosillon, Laurence Baril, Maria Rowena Del Rosario‐Raymundo, Cosette Marie Wheeler, Susan Rachel Skinner, Suzanne Marie Garland, Jorge Salmeron, Eduardo Lazcano‐Ponce, Carlos Santiago Vallejos, Tanya Stoney, Bram ter Harmsel, Timothy Yong Kuei Lim, Swee Chong Quek, Galina Minkina, Shelly Ann McNeil, Celine Bouchard, Kah Leng Fong, Deborah Money, Arunachalam Ilancheran, Alevtina Savicheva, Margaret Cruickshank, Archana Chatterjee, Alison Fiander, Mark Martens, Marie Cecile Bozonnat, Frank Struyf, Gary Dubin, Xavier Castellsagué
Publikováno v:
Cancer Medicine, Vol 8, Iss 10, Pp 4938-4953 (2019)
Abstract Background Infections with human papillomavirus (HPV) types 16 and 18 account for ~70% of invasive cervical cancers but the degree of protection from naturally acquired anti‐HPV antibodies is uncertain. We examined the risk of HPV infectio
Externí odkaz:
https://doaj.org/article/40e9a77e561148afa8859397e1b7d125